Kali, Inc. (KALY)
OTCMKTS · Delayed Price · Currency is USD
0.0000
0.00 (0.00%)
At close: Aug 18, 2025
Kali, Inc. Revenue
Kali, Inc. had revenue of $26.61M in the quarter ending March 31, 2013, with 75.48% growth. This brings the company's revenue in the last twelve months to $105.99M, up 27.98% year-over-year. In the year 2012, Kali, Inc. had annual revenue of $94.55M with 6.44% growth.
Revenue (ttm)
105.99M
Revenue Growth
+27.98%
P/S Ratio
0.00
Revenue / Employee
619.84K
Employees
171
Market Cap
1.54K
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2012 | 94.55M | 5.72M | 6.44% |
| Dec 31, 2011 | 88.83M | 14.99M | 20.31% |
| Dec 31, 2010 | 73.83M | 9.49M | 14.75% |
| Dec 31, 2009 | 64.34M | 12.48M | 24.05% |
| Dec 31, 2008 | 51.87M | 12.14M | 30.56% |
| Dec 31, 2007 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2006 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Veradigm | 588.02M |
| Glass House Brands | 221.55M |
| Tian'an Technology Group | 1.78M |
| Elite Pharmaceuticals | 105.45M |
| American Oncology Network | 1.76B |
| Northwest Biotherapeutics | 1.09M |
| Silence Therapeutics | 27.17M |
| Global Cord Blood | 196.10M |